NCT02570022View on ClinicalTrials.gov

Liposomal Bupivacaine in Total Shoulder Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Pain
Interventions
DRUG

Liposomal bupivacaine

Local infiltration of liposomal bupivacaine

PROCEDURE

Inter-scalene nerve block

Pre-operative inter-scalene nerve block

DRUG

Ropivacaine

Ropivicaine was used for the inter-scalene nerve block.

Trial Locations (1)

48202

Henry Ford Health System, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT02570022 - Liposomal Bupivacaine in Total Shoulder Arthroplasty | Biotech Hunter | Biotech Hunter